These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3508183)

  • 1. The effect of niosomes and polysorbate 80 on the metabolism and excretion of methotrexate in the mouse.
    Azmin MN; Florence AT; Handjani-Vila RM; Stuart JF; Vanlerberghe G; Whittaker JS
    J Microencapsul; 1986; 3(2):95-100. PubMed ID: 3508183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice.
    Azmin MN; Florence AT; Handjani-Vila RM; Stuart JF; Vanlerberghe G; Whittaker JS
    J Pharm Pharmacol; 1985 Apr; 37(4):237-42. PubMed ID: 2860220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice.
    Chandraprakash KS; Udupa N; Umadevi P; Pillai GK
    J Drug Target; 1993; 1(2):143-5. PubMed ID: 8069552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice.
    Azmin MN; Stuart JF; Calman KC; Florence AT
    Cancer Chemother Pharmacol; 1982; 9(3):161-4. PubMed ID: 7160051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
    Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
    J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80.
    Azmin MN; Stuart JF; Florence AT
    Cancer Chemother Pharmacol; 1985; 14(3):238-42. PubMed ID: 3995684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies.
    Sihorkar V; Vyas SP
    Pharmazie; 2000 Feb; 55(2):107-13. PubMed ID: 10723768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin-loaded niosomes: drug entrapment, stability and release.
    Rogerson A; Cummings J; Florence AT
    J Microencapsul; 1987; 4(4):321-8. PubMed ID: 3504513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 Nov; 49(22):6359-64. PubMed ID: 2804982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
    Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
    J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the preparation of camptothecin niosomes].
    Luan LB; Zhu JB; Yu WP; Wei KB
    Yao Xue Xue Bao; 2002 Jan; 37(1):59-62. PubMed ID: 12579902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysorbate 20 non-ionic surfactant enhances retinal gene delivery efficiency of cationic niosomes after intravitreal and subretinal administration.
    Villate-Beitia I; Gallego I; Martínez-Navarrete G; Zárate J; López-Méndez T; Soto-Sánchez C; Santos-Vizcaíno E; Puras G; Fernández E; Pedraz JL
    Int J Pharm; 2018 Oct; 550(1-2):388-397. PubMed ID: 30009984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased intestinal absorption of methotrexate in the rat following repeated oral dosing.
    Sonneveld P; Storm AJ; Nooter K
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):133-6. PubMed ID: 3992025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of niosomes containing rifampicin for lung targeting.
    Jain CP; Vyas SP
    J Microencapsul; 1995; 12(4):401-7. PubMed ID: 8583314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.
    Kimelberg HK; Tracy TF; Biddlecome SM; Bourke RS
    Cancer Res; 1976 Aug; 36(8):2949-57. PubMed ID: 819137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An electron spin resonance study of non-ionic surfactant vesicles (niosomes).
    Yeom S; Shin BS; Han S
    Chem Phys Lipids; 2014 Jul; 181():83-9. PubMed ID: 24721595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.
    Paliwal R; Paliwal SR; Mishra N; Mehta A; Vyas SP
    Int J Pharm; 2009 Oct; 380(1-2):181-8. PubMed ID: 19576973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.